Nuveen Asset Management LLC Has $17.77 Million Stock Position in Azenta, Inc. (NASDAQ:AZTA)

Nuveen Asset Management LLC lifted its position in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 95.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 355,375 shares of the company's stock after acquiring an additional 173,699 shares during the period. Nuveen Asset Management LLC owned approximately 0.78% of Azenta worth $17,769,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in AZTA. Millennium Management LLC grew its position in Azenta by 19.8% in the fourth quarter. Millennium Management LLC now owns 108,175 shares of the company's stock valued at $5,409,000 after acquiring an additional 17,899 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Azenta by 13.8% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 50,507 shares of the company's stock valued at $2,523,000 after purchasing an additional 6,139 shares in the last quarter. Gotham Asset Management LLC boosted its stake in shares of Azenta by 388.2% in the 4th quarter. Gotham Asset Management LLC now owns 198,050 shares of the company's stock valued at $9,902,000 after purchasing an additional 157,483 shares in the last quarter. Focus Partners Wealth grew its holdings in shares of Azenta by 7.2% during the 4th quarter. Focus Partners Wealth now owns 13,738 shares of the company's stock valued at $690,000 after purchasing an additional 921 shares during the last quarter. Finally, Deutsche Bank AG increased its position in Azenta by 28.5% during the 4th quarter. Deutsche Bank AG now owns 4,199 shares of the company's stock worth $210,000 after purchasing an additional 931 shares in the last quarter. Institutional investors and hedge funds own 99.08% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on AZTA. Needham & Company LLC cut their target price on shares of Azenta from $59.00 to $40.00 and set a "buy" rating on the stock in a research report on Wednesday, May 7th. Evercore ISI raised their price objective on Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a report on Thursday, February 6th. Finally, TD Cowen upgraded Azenta to a "hold" rating in a research report on Thursday, February 27th.

Azenta Trading Down 1.6%

NASDAQ:AZTA traded down $0.44 during mid-day trading on Wednesday, hitting $27.28. 408,204 shares of the company's stock were exchanged, compared to its average volume of 691,271. Azenta, Inc. has a fifty-two week low of $23.91 and a fifty-two week high of $63.58. The firm has a market capitalization of $1.25 billion, a P/E ratio of -9.16 and a beta of 1.64. The company has a 50 day simple moving average of $28.65 and a 200-day simple moving average of $40.72.

Azenta (NASDAQ:AZTA - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.04). Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. During the same quarter in the prior year, the company posted $0.06 EPS. The firm's revenue for the quarter was up 5.1% on a year-over-year basis. As a group, analysts expect that Azenta, Inc. will post 0.53 earnings per share for the current year.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.